Q4 2026 Balaji Amines Ltd Earnings Call Transcript
Key Points
- Balaji Amines Ltd (BOM:530999) reported a 12% year-on-year revenue growth for Q4 FY26, reaching INR403 crore.
- The company's EBITDA margin improved significantly to 25% in Q4 FY26 from 19% in Q4 FY25.
- Balaji Amines Ltd remains a zero-debt company, showcasing strong financial discipline.
- The company is making strategic progress with new projects like dimethyl ether (DME) and N-Methylmorpholine (NMM), expected to be commissioned in FY27.
- The company has a strong integrated manufacturing model and supply chain capabilities, which helped manage disruptions effectively.
- The company's capacity utilization is relatively low, operating at 35%-40%, raising questions about the need for further expansions.
- There are concerns about the geopolitical situation affecting raw material prices, which have increased significantly.
- Balaji Amines Ltd's subsidiary faced challenges with high raw material costs, impacting gross margins.
- The company is awaiting government approvals for DME transportation, which could delay revenue realization.
- There is uncertainty regarding the impact of a large customer's backward integration on Balaji Amines Ltd's methylamines business.
Ladies and Gentlemen, good day and welcome to the Balaji Amines Limited Q4 FY26 Earnings Conference Call. (Operator Instructions) Please note that this conference has been recorded. I now hand the conference over to Mr. Gagan Dixit from Elara Securities. Thank you, and over to you, sir.
()-
Yes, thank you. Very warm welcome to everyone to discuss Balaji Amines Q4 FY26 event. It is our pleasure to be able to bring to you the event of Balaji Amines Limited, led by Mr. D. Ram Reddy, who is the Managing Director. We would also like this opportunity to congratulate the management on its excellent set of numbers. With these words, I would now hand over the conference to the Balaji Amines management. Over to you, sir.
Thank you, Gagan. Good evening, everyone, and a warm welcome to Balaji Amines Limited's earnings conference call for the fourth
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
